Recently, Galderma, the makers of Sculptra and Restylane, completed a landmark 9-month Phase IV clinical trialthe first study evaluating Sculptra combined with HA fillers specifically for GLP-1related volume loss
As treatment progresses, these shifts, combined with lifestyle changes, foster meaningful weight management that continues over time
Ozempic, a semaglutide-based medication, is specifically designed for adults managing type 2 diabetes by mimicking the GLP-1 hormone that controls blood sugar levels
It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
Two reasons: Raw ingredient cost: Tirzepatide raw material is more expensive to produce than semaglutide due to its larger, more complex molecular structure (39 amino acids with a C20 fatty diacid moiety)